Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma

Biomaterials
Young-Eun SeoW Mark Saltzman

Abstract

Glioblastoma (GBM) is the most common and deadly form of malignant brain tumor in the United States, and current therapies fail to provide significant improvement in survival. Local delivery of nanoparticles is a promising therapeutic strategy that bypasses the blood-brain barrier, minimizes systemic toxicity, and enhances intracranial drug distribution and retention. Here, we developed nanoparticles loaded with agents that inhibit miR-21, an oncogenic microRNA (miRNA) that is strongly overexpressed in GBM compared to normal brain tissue. We synthesized, engineered, and characterized two different delivery systems. One was designed around an anti-miR-21 composed of RNA and employed a cationic poly(amine-co-ester) (PACE). The other was designed around an anti-miR-21 composed of peptide nucleic acid (PNA) and employed a block copolymer of poly(lactic acid) and hyperbranched polyglycerol (PLA-HPG). We show that both nanoparticle products facilitate efficient intracellular delivery and miR-21 suppression that leads to PTEN upregulation and apoptosis of human GBM cells. Further, when administered by convection-enhanced delivery (CED) to animals with intracranial gliomas, they both induced significant miR-21 knockdown and provided ch...Continue Reading

Citations

Dec 5, 2019·Cancer Metastasis Reviews·Julia Alejandra PezukMaría Sol Brassesco
Apr 25, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Soumen SahaArabinda Chaudhuri
Dec 22, 2019·International Journal of Molecular Sciences·Giuseppina Emanuela GriecoGuido Sebastiani
Oct 9, 2019·British Journal of Biomedical Science·P Waller, A D Blann
Jun 26, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Aniket WahaneRaman Bahal
Jul 15, 2020·Cancers·Alexis ForterreMasako Harada
Aug 9, 2020·Frontiers in Immunology·Syreeta DeCordovaUday Kishore
Nov 12, 2020·Nature Communications·Jason V GregoryJoerg Lahann
Dec 15, 2020·Biomaterials Science·João ConniotJoão Conde
Apr 18, 2020·Seminars in Cancer Biology·Faheem Hyder PottooFirdos Alam Khan
Jan 28, 2021·Methods and Protocols·Ishani Dasgupta, Anushila Chatterjee
Feb 13, 2021·AAPS PharmSciTech·Kanawat WiwatchaitaweeAliasger K Salem
Dec 1, 2020·Toxicology Reports·Athina-Maria AloizouEfthimios Dardiotis
Nov 14, 2020·International Journal of Biological Macromolecules·Dnyandev GadhaveChandrakant Kokare
May 12, 2021·Advanced Healthcare Materials·Deidra M WardNicholas A Peppas
Jun 3, 2021·Cancers·Soha Reda El SayedNadia Cherradi
Oct 4, 2020·Experimental and Molecular Pathology·Omidvar RezaeiSoudeh Ghafouri-Fard
Oct 1, 2021·Future Medicinal Chemistry·Ashutosh SinghNeha Garg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis